By proceeding, you agree to our Terms of Use and Privacy Policy.
David Mills is currently Director, Preclinical Science at Ambrx. Before this, he served as Director, Oncology of Zymeworks Inc. David's earlier stints are Kyowa Hakko Kirin California, Arena Pharmaceuticals, Inc.
Talks About #oncology #clinicalscience
Preferred Locations #NorthAmerica
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
